The diagnostic performance of NRG1, miR-382-5p, and lncRNA Ftx for distinguishing MS and NMO from healthy controls, as well as between MS and NMO, is summarized in Supplementary Table 1. The gene discussed is NRG1; the disease is myeloid sarcoma.